 |
 |
VIEW - September 2009 The Upside of the Downturn By Carolyn Gretton “Patients are making fewer doctor visits and some patients are not filling or refilling prescriptions as directed by their physicians,” notes Deirdre Connelly, president, North American pharmaceuticals, for GlaxoSmithKline (GSK). “Given the challenging economic environment we’ve seen over the last year, we’ve increased our focus on being more efficient and effective in delivering value to our customers in every interaction we have.” Meaghan Onofrey, president of MBS/Vox, part of CommonHealth, concurs that the current recession has altered the landscape dramatically. “Discussions of cost within the healthcare professional-patient dialogue have become more and more common,” she says. “Interestingly enough, physicians are just as likely to raise this topic as are patients. The topic is no longer taboo, and the playing field is more level. Our culture is slowly shifting into one that puts an emphasis on value. Healthcare professionals and patients can align on the need to save money whenever possible.” Ms. Onofrey says fostering an appropriate healthcare professional-patient dialogue about value, and how to deal with cost beyond cut-backs, can ensure that patients... Sidebar: Industry’s Image Gains Ground in U.S., Stumbles in Europe Companies rated “excellent” in terms of reputation ViewPoint Thought Leaders Deirdre Connelly. President, North American Pharmaceuticals, GlaxoSmithKline Plc., one of the world’s leading research-based pharmaceutical and healthcare companies. For more information, visit gsk.com. Mike Derkacz. VP, U.S. Marketing, CNS, Cephalon Inc., an international biopharmaceutical company dedicated to the discovery, development, and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain, and oncology. For more information, visit cephalon.com. Josh Franklin. VP, Sales and Marketing, Cornerstone Therapeutics Inc., a specialty company focused on medications for respiratory disorders, For more information, visit crtx.com. Walt Johnson. VP of Marketing, Astellas US LLC, an affiliate of Astellas Pharma Inc., which is dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, visit us.astellas.com. Chris Mario. VP, Marketing and Commercial Development, Neuropharm Inc., the U.S. division of Neuropharm Group Plc., a specialty company focused on developing medicines for neuro-developmental disorders. For more information, visit neuropharm.co.uk.
|
